INO – inovio pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
11/18
01:06 pm
ino
Low
Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
11/18
12:38 pm
ino
Low
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at HC Wainwright from $12.00 to $5.00. They now have a "neutral" rating on the stock.
11/18
09:27 am
ino
Medium
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $33.00 to $15.00. They now have an "outperform" rating on the stock.
11/16
09:10 am
ino
Medium
Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) [Yahoo! Finance]
11/15
01:19 pm
ino
Low
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $7.00 to $6.00. They now have a "sector perform" rating on the stock.
11/14/2024
04:05 pm
ino
-11.0%
BEAT
8/8/2024
04:05 pm
ino
-6.5%
MISS
5/13/2024
04:05 pm
ino
-2.2%
MISS
3/6/2024
04:05 pm
ino
-11.9%
BEAT
11/18
08:53 am
Maintains
Outperform
Outperform
Oppenheimer
Medium
-8.8%
11/18
08:53 am
Maintains
Outperform
Outperform
Oppenheimer
Medium
-8.8%
11/15
12:29 pm
Maintains
Sector Perform
Sector Perform
RBC Capital
Low
-0.4%
11/15
12:29 pm
Maintains
Sector Perform
Sector Perform
RBC Capital
Low
-0.4%
10/4
11:41 am
Maintains
Sector Perform
Sector Perform
RBC Capital
Low
-2.8%
11/14
04:10 pm
ino
High
Form 8-K INOVIO PHARMACEUTICALS, For: Nov 14
11/14
04:02 pm
ino
High
Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30
11/8
02:22 pm
ino
Low
Form SC 13G INOVIO PHARMACEUTICALS, Filed by: BlackRock, Inc.
10/22
06:08 pm
ino
Low
Form SC 13G INOVIO PHARMACEUTICALS, Filed by: BlackRock, Inc.
Show more
Top News Gainers
3/3 Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800 66.7%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
Top News Decliners
3/9 Form 8-K INOVIO PHARMACEUTICALS, For: Mar 03 -47.6%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3